213 related articles for article (PubMed ID: 36482860)
1. Gestational thyroid hormone concentrations and risk of attention-deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study.
Engel SM; Villanger GD; Herring A; Nethery RC; Drover SSM; Zoeller RT; Meltzer HM; Zeiner P; Knudsen GP; Reichborn-Kjennerud T; Longnecker MP; Aase H
Paediatr Perinat Epidemiol; 2023 Mar; 37(3):218-228. PubMed ID: 36482860
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy exposure to organophosphate esters and the risk of attention-deficit hyperactivity disorder in the Norwegian mother, father and child cohort study.
Choi G; Keil AP; Richardson DB; Daniels JL; Hoffman K; Villanger GD; Sakhi AK; Thomsen C; Reichborn-Kjennerud T; Aase H; Engel SM
Environ Int; 2021 Sep; 154():106549. PubMed ID: 33910116
[TBL] [Abstract][Full Text] [Related]
3. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
[TBL] [Abstract][Full Text] [Related]
4. Organophosphorus Pesticide Exposure at 17 Weeks' Gestation and Odds of Offspring Attention-Deficit/Hyperactivity Disorder Diagnosis in the Norwegian Mother, Father, and Child Cohort Study.
Hall AM; Thistle JE; Manley CK; Roell KR; Ramos AM; Villanger GD; Reichborn-Kjennerud T; Zeiner P; Cequier E; Sakhi AK; Thomsen C; Aase H; Engel SM
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554732
[TBL] [Abstract][Full Text] [Related]
5. The impact of gestational thyroid hormone concentrations on ADHD symptoms of the child.
Päkkilä F; Männistö T; Pouta A; Hartikainen AL; Ruokonen A; Surcel HM; Bloigu A; Vääräsmäki M; Järvelin MR; Moilanen I; Suvanto E
J Clin Endocrinol Metab; 2014 Jan; 99(1):E1-8. PubMed ID: 24384024
[TBL] [Abstract][Full Text] [Related]
6. Neonatal thyroid-stimulating hormone and association with attention-deficit/hyperactivity disorder.
Villanger GD; Ystrom E; Engel SM; Longnecker MP; Pettersen R; Rowe AD; Reichborn-Kjennerud T; Aase H
Paediatr Perinat Epidemiol; 2020 Sep; 34(5):590-596. PubMed ID: 32072662
[TBL] [Abstract][Full Text] [Related]
7. Maternal Iodine Intake and Offspring Attention-Deficit/Hyperactivity Disorder: Results from a Large Prospective Cohort Study.
Abel MH; Ystrom E; Caspersen IH; Meltzer HM; Aase H; Torheim LE; Askeland RB; Reichborn-Kjennerud T; Brantsæter AL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137191
[TBL] [Abstract][Full Text] [Related]
8. Associations between urine phthalate metabolites and thyroid function in pregnant women and the influence of iodine status.
Villanger GD; Drover SSM; Nethery RC; Thomsen C; Sakhi AK; Øvergaard KR; Zeiner P; Hoppin JA; Reichborn-Kjennerud T; Aase H; Engel SM
Environ Int; 2020 Apr; 137():105509. PubMed ID: 32044443
[TBL] [Abstract][Full Text] [Related]
9. Prenatal Phthalates, Maternal Thyroid Function, and Risk of Attention-Deficit Hyperactivity Disorder in the Norwegian Mother and Child Cohort.
Engel SM; Villanger GD; Nethery RC; Thomsen C; Sakhi AK; Drover SSM; Hoppin JA; Zeiner P; Knudsen GP; Reichborn-Kjennerud T; Herring AH; Aase H
Environ Health Perspect; 2018 May; 126(5):057004. PubMed ID: 29790729
[TBL] [Abstract][Full Text] [Related]
10. Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD).
Baker BH; Wu H; Laue HE; Boivin A; Gillet V; Langlois MF; Bellenger JP; Baccarelli AA; Takser L
Environ Int; 2020 Jun; 139():105716. PubMed ID: 32283359
[TBL] [Abstract][Full Text] [Related]
11. Metal and essential element concentrations during pregnancy and associations with autism spectrum disorder and attention-deficit/hyperactivity disorder in children.
Skogheim TS; Weyde KVF; Engel SM; Aase H; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Caspersen IH; Hornig M; Haug LS; Villanger GD
Environ Int; 2021 Jul; 152():106468. PubMed ID: 33765546
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
13. Maternal Fiber Intake During Pregnancy and Development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father, and Child Cohort Study.
Solberg BS; Kvalvik LG; Instanes JT; Hartman CA; Klungsøyr K; Li L; Larsson H; Magnus P; Njølstad PR; Johansson S; Andreassen OA; Bakken NR; Bekkhus M; Austerberry C; Smajlagic D; Havdahl A; Corfield EC; Haavik J; Gjestad R; Zayats T
Biol Psychiatry; 2024 May; 95(9):839-848. PubMed ID: 38142720
[TBL] [Abstract][Full Text] [Related]
14. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
[TBL] [Abstract][Full Text] [Related]
15. Association of sweetened carbonated beverage consumption during pregnancy and ADHD symptoms in the offspring: a study from the Norwegian Mother, Father and Child Cohort Study (MoBa).
Kvalvik LG; Klungsøyr K; Igland J; Caspersen IH; Brantsæter AL; Solberg BS; Hartman C; Schweren LJS; Larsson H; Li L; Forthun I; Johansson S; Arias Vasquez A; Haavik J
Eur J Nutr; 2022 Jun; 61(4):2153-2166. PubMed ID: 35066701
[TBL] [Abstract][Full Text] [Related]
16. Maternal Thyroid Function in Early Pregnancy and Child Attention-Deficit Hyperactivity Disorder: An Individual-Participant Meta-Analysis.
Levie D; Korevaar TIM; Mulder TA; Bath SC; Dineva M; Lopez-Espinosa MJ; Basterrechea M; Santa-Marina L; Rebagliato M; Sunyer J; Rayman MP; Tiemeier H; Peeters RP; Guxens M
Thyroid; 2019 Sep; 29(9):1316-1326. PubMed ID: 31426724
[No Abstract] [Full Text] [Related]
17. Maternal Iodine Status During Pregnancy Is Not Consistently Associated with Attention-Deficit Hyperactivity Disorder or Autistic Traits in Children.
Levie D; Bath SC; Guxens M; Korevaar TIM; Dineva M; Fano E; Ibarluzea JM; Llop S; Murcia M; Rayman MP; Sunyer J; Peeters RP; Tiemeier H
J Nutr; 2020 Jun; 150(6):1516-1528. PubMed ID: 32171006
[TBL] [Abstract][Full Text] [Related]
18. Maternal Thyroid Anomalies and Attention-Deficit Hyperactivity Disorder in Progeny.
Rotem RS; Chodick G; Davidovitch M; Bellavia A; Weisskopf MG
Am J Epidemiol; 2022 Feb; 191(3):430-440. PubMed ID: 34791037
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort.
Hjorth S; Lupattelli A; Handal M; Spigset O; Ystrom E; Nordeng H
Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1380-1390. PubMed ID: 33866622
[TBL] [Abstract][Full Text] [Related]
20. Maternal Thyroid Hormone Replacement Therapy Exposure and Language and Communication Skills of Offspring at 8 Years of Age.
Frank AS; Lupattelli A; Brandlistuen RE; Nordeng H
JAMA Netw Open; 2019 Oct; 2(10):e1912424. PubMed ID: 31577359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
